Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review

Nucleic acid vaccines have been gaining attention as an alternative to the standard attenuated pathogen or protein based vaccine. However, an unrealized advantage of using such DNA or RNA based vaccination modalities is the ability to program within these nucleic acids regulatory devices that would provide an immunologist with the power to control the production of antigens and adjuvants in a desirable manner by administering small molecule drugs as chemical triggers. Advances in synthetic biology have resulted in the creation of highly predictable and modular genetic parts and devices that can be composed into synthetic gene circuits with complex behaviors. With the recent advent of modified RNA gene delivery methods and developments in the RNA replicon platform, we foresee a future in which mammalian synthetic biologists will create genetic circuits encoded exclusively on RNA. Here, we review the current repertoire of devices used in RNA synthetic biology and propose how programmable ‘smart vaccines’ will revolutionize the field of RNA vaccination.

[1]  A. Serganov,et al.  A Decade of Riboswitches , 2013, Cell.

[2]  Dobb's journal staff Of interest , 2001, Administration in mental health.

[3]  Michael Basler,et al.  Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression1 , 2003, The Journal of Immunology.

[4]  K. Lundstrom Alphavirus-Based Vaccines. , 2016, Methods in molecular biology.

[5]  Philip C. Bevilacqua,et al.  Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation , 2010, Nucleic acids research.

[6]  Ben Turner,et al.  Induced fit of RNA on binding the L7Ae protein to the kink-turn motif. , 2005, RNA.

[7]  Beatrix Suess,et al.  Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast , 2007, Nucleic acids research.

[8]  Steven J. Seedhouse,et al.  Structure-activity relationships through sequencing (StARTS) defines optimal and suboptimal RNA motif targets for small molecules. , 2010, Angewandte Chemie.

[9]  Beatrix Suess,et al.  Screening for engineered neomycin riboswitches that control translation initiation. , 2007, RNA.

[10]  R. Sachidanandam,et al.  An in vivo RNAi screening approach to identify host determinants of virus replication. , 2013, Cell host & microbe.

[11]  T. Wandless,et al.  A general chemical method to regulate protein stability in the mammalian central nervous system. , 2010, Chemistry & biology.

[12]  Christina D Smolke,et al.  Synthetic RNA switches as a tool for temporal and spatial control over gene expression. , 2012, Current opinion in biotechnology.

[13]  A. Muotri,et al.  Efficient generation of human iPSCs by a synthetic self-replicative RNA. , 2013, Cell stem cell.

[14]  Hirohide Saito,et al.  Synthetic human cell fate regulation by protein-driven RNA switches , 2011, Nature Communications.

[15]  Ian Small,et al.  The potential for manipulating RNA with pentatricopeptide repeat proteins. , 2014, The Plant journal : for cell and molecular biology.

[16]  E. Luman,et al.  The need for innovative strategies to improve immunisation services in rural Zimbabwe. , 2012, Disasters.

[17]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[18]  E. Westhof,et al.  Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity , 2003, Nature Structural Biology.

[19]  K. Dery,et al.  Ligand-induced sequestering of branchpoint sequence allows conditional control of splicing , 2008, BMC Molecular Biology.

[20]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[21]  Yohei Yokobayashi,et al.  Artificial control of gene expression in mammalian cells by modulating RNA interference through aptamer-small molecule interaction. , 2006, RNA.

[22]  C. Barreau,et al.  Tethering of proteins to RNAs by bacteriophage proteins , 2008, Biology of the cell.

[23]  Martin Fussenegger,et al.  From gene switches to mammalian designer cells: present and future prospects. , 2013, Trends in biotechnology.

[24]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[25]  K. Lundstrom Alphavirus-Based Vaccines , 2002, Viruses.

[26]  Beatrix Suess,et al.  Mechanistic insights into an engineered riboswitch: a switching element which confers riboswitch activity , 2010, Nucleic acids research.

[27]  Christopher A. Voigt,et al.  Principles of genetic circuit design , 2014, Nature Methods.

[28]  Tomoaki Hara,et al.  Synthetic translational regulation by an L7Ae-kink-turn RNP switch. , 2010, Nature chemical biology.

[29]  Steven J. Seedhouse,et al.  Two-dimensional combinatorial screening and the RNA Privileged Space Predictor program efficiently identify aminoglycoside–RNA hairpin loop interactions , 2009, Nucleic acids research.

[30]  Markus Wieland,et al.  Rational design of a small molecule-responsive intramer controlling transgene expression in mammalian cells , 2011, Nucleic acids research.

[31]  Byoung-Tak Zhang,et al.  Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex , 2006, Cell.

[32]  D. Weissman,et al.  Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L , 2011, Nucleic acids research.

[33]  Martin Fussenegger,et al.  Reward-based hypertension control by a synthetic brain–dopamine interface , 2013, Proceedings of the National Academy of Sciences.

[34]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Yohei Yokobayashi,et al.  Combinatorially inducible RNA interference triggered by chemically modified oligonucleotides. , 2011, Journal of the American Chemical Society.

[36]  John J. Rossi,et al.  Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy , 2014, Molecular therapy. Nucleic acids.

[37]  J. Doudna,et al.  Molecular mechanisms of RNA interference. , 2013, Annual review of biophysics.

[38]  Chase L. Beisel,et al.  Design of small molecule-responsive microRNAs based on structural requirements for Drosha processing , 2010, Nucleic acids research.

[39]  Karl-Dieter Entian,et al.  A fast and efficient translational control system for conditional expression of yeast genes , 2009, Nucleic acids research.

[40]  Christina D Smolke,et al.  Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins , 2010, Science.

[41]  M. Win,et al.  A modular and extensible RNA-based gene-regulatory platform for engineering cellular function , 2007, Proceedings of the National Academy of Sciences.

[42]  J. Rosenecker,et al.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.

[43]  Matthew D Disney,et al.  Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners. , 2008, Journal of the American Chemical Society.

[44]  R. Stoltenburg,et al.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.

[45]  Yang Wang,et al.  Engineering RNA Endonucleases with Customized Sequence Specificities , 2012, Nature Communications.

[46]  N. Sonenberg,et al.  Principles of translational control: an overview. , 2012, Cold Spring Harbor perspectives in biology.

[47]  J. H. Strauss,et al.  The Alphaviruses: Gene Expression, Replication, and Evolution , 1994, Microbiological reviews.

[48]  Carola Engler,et al.  A One Pot, One Step, Precision Cloning Method with High Throughput Capability , 2008, PloS one.

[49]  J. Burnett,et al.  RNA-based therapeutics: current progress and future prospects. , 2012, Chemistry & biology.

[50]  D. Schaffer,et al.  Bidirectional regulation of mRNA translation in mammalian cells by using PUF domains. , 2014, Angewandte Chemie.

[51]  Barbara Fink,et al.  Conditional gene expression by controlling translation with tetracycline-binding aptamers. , 2003, Nucleic acids research.

[52]  B. Suess,et al.  Mechanistic Basis for RNA Aptamer‐Based Induction of TetR , 2011, Chembiochem : a European journal of chemical biology.

[53]  R. Gaur,et al.  An artificial riboswitch for controlling pre-mRNA splicing. , 2005, RNA.

[54]  M. Wickens,et al.  Targeted translational regulation using the PUF protein family scaffold , 2011, Proceedings of the National Academy of Sciences.

[55]  L. Naldini,et al.  Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer , 2006, Nature Medicine.

[56]  Christina D Smolke,et al.  Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems , 2010, Proceedings of the National Academy of Sciences.

[57]  Martin Fussenegger,et al.  Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome , 2012, Proceedings of the National Academy of Sciences.

[58]  E. Gilboa,et al.  Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay , 2010, Nature.

[59]  Yen-Hsiang Wang,et al.  Synthetic biology: advancing the design of diverse genetic systems. , 2013, Annual review of chemical and biomolecular engineering.

[60]  Jon R Lorsch,et al.  The mechanism of eukaryotic translation initiation: new insights and challenges. , 2012, Cold Spring Harbor perspectives in biology.

[61]  Brian J. Belmont,et al.  Inducible Control of Subcellular RNA Localization Using a Synthetic Protein-RNA Aptamer Interaction , 2012, PloS one.

[62]  Brian J. Belmont,et al.  Engineering a direct and inducible protein-RNA interaction to regulate RNA biology. , 2010, ACS chemical biology.

[63]  Hirohide Saito,et al.  A versatile cis-acting inverter module for synthetic translational switches , 2013, Nature Communications.

[64]  R. Weiss,et al.  Foundations for the design and implementation of synthetic genetic circuits , 2012, Nature Reviews Genetics.

[65]  Aleksandra Filipovska,et al.  A universal code for RNA recognition by PUF proteins. , 2011, Nature chemical biology.

[66]  Zhen Xie,et al.  Logic integration of mRNA signals by an RNAi-based molecular computer , 2010, Nucleic acids research.

[67]  Hiroki Kato,et al.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[68]  Yohei Yokobayashi,et al.  Conditional RNA interference mediated by allosteric ribozyme. , 2009, Journal of the American Chemical Society.

[69]  L. Peelman,et al.  Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Steven M. Gallo,et al.  Sequence-based design of bioactive small molecules that target precursor microRNAs , 2014, Nature chemical biology.

[71]  T. Wandless,et al.  Destabilizing domains derived from the human estrogen receptor. , 2012, Journal of the American Chemical Society.

[72]  Luc Jaeger,et al.  RNA modularity for synthetic biology , 2013, F1000prime reports.

[73]  Roger Y Tsien,et al.  Control of mammalian translation by mRNA structure near caps. , 2006, RNA.

[74]  Jacob J. Hughey,et al.  High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells , 2014, Cell.

[75]  Huimin Zhao,et al.  Modular assembly of designer PUF proteins for specific post-transcriptional regulation of endogenous RNA , 2014, Journal of biological engineering.

[76]  Özlem Türeci,et al.  mRNA-based therapeutics — developing a new class of drugs , 2014, Nature Reviews Drug Discovery.

[77]  Daniel G. Anderson,et al.  Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.

[78]  L. Peelman,et al.  Comparison of the gene transfer efficiency of mRNA/GL67 and pDNA/GL67 complexes in respiratory cells. , 2012, Molecular Pharmaceutics.

[79]  Jerry Pelletier,et al.  Inhibition of translation by RNA-small molecule interactions. , 2002, RNA.

[80]  D. Turner,et al.  Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[81]  K. White,et al.  Higher-Order RNA Structural Requirements and Small-Molecule Induction of Tombusvirus Subgenomic mRNA Transcription , 2008, Journal of Virology.

[82]  Y. Liu,et al.  Structural basis for the modular recognition of single-stranded RNA by PPR proteins , 2013, Nature.

[83]  P. Rod Dunbar,et al.  Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols1 , 2002, The Journal of Immunology.

[84]  Simon Ausländer,et al.  A ligand-dependent hammerhead ribozyme switch for controlling mammalian gene expression. , 2010, Molecular bioSystems.

[85]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[86]  James A. Stapleton,et al.  Quantitative and simultaneous translational control of distinct mammalian mRNAs , 2013, Nucleic acids research.

[87]  J. Collins,et al.  Construction of a genetic toggle switch in Escherichia coli , 2000, Nature.

[88]  S. Almo,et al.  Aptamer-targeted Antigen Delivery , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[89]  F. Zepp Principles of vaccine design-Lessons from nature. , 2010, Vaccine.

[90]  M. Elowitz,et al.  A synthetic oscillatory network of transcriptional regulators , 2000, Nature.

[91]  H. Park,et al.  High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice , 2011, PloS one.

[92]  Thomas Krucker,et al.  Nonviral delivery of self-amplifying RNA vaccines , 2012, Proceedings of the National Academy of Sciences.

[93]  A. Ferré-D’Amaré,et al.  Small self-cleaving ribozymes. , 2010, Cold Spring Harbor perspectives in biology.

[94]  Yang Wang,et al.  Engineering splicing factors with designed specificities , 2009, Nature Methods.

[95]  Martin Fussenegger,et al.  Synthetic mammalian gene circuits for biomedical applications. , 2013, Current opinion in chemical biology.

[96]  R. Weiss,et al.  A universal RNAi-based logic evaluator that operates in mammalian cells , 2007, Nature Biotechnology.

[97]  C. Contag,et al.  Chemical control of protein stability and function in living mice , 2008, Nature Medicine.

[98]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[99]  William I. Bacchus,et al.  Biomedically relevant circuit-design strategies in mammalian synthetic biology , 2013, Molecular systems biology.

[100]  Charles S. Bond,et al.  A Combinatorial Amino Acid Code for RNA Recognition by Pentatricopeptide Repeat Proteins , 2012, PLoS genetics.

[101]  Houping Ni,et al.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. , 2005, Immunity.

[102]  Martin Fussenegger,et al.  A designer cell-based histamine-specific human allergy profiler , 2014, Nature Communications.

[103]  R R Breaker,et al.  Rational design of allosteric ribozymes. , 1997, Chemistry & biology.

[104]  Zhen Xie,et al.  Rationally-designed logic integration of regulatory signals in mammalian cells , 2010, Nature nanotechnology.

[105]  G. Vanham,et al.  Challenges and advances towards the rational design of mRNA vaccines. , 2013, Trends in molecular medicine.

[106]  Corey W. Liu,et al.  Small molecule displacement of a cryptic degron causes conditional protein degradation , 2011, Nature chemical biology.

[107]  Yaakov Benenson,et al.  Synthetic biology with RNA: progress report. , 2012, Current opinion in chemical biology.

[108]  M. Win,et al.  Higher-Order Cellular Information Processing with Synthetic RNA Devices , 2008, Science.

[109]  Brian J. Belmont,et al.  Direct and specific chemical control of eukaryotic translation with a synthetic RNA–protein interaction , 2012, Nucleic acids research.

[110]  Jacob Beal,et al.  Model-driven engineering of gene expression from RNA replicons. , 2015, ACS synthetic biology.

[111]  S. Pascolo Vaccination with messenger RNA (mRNA). , 2008, Handbook of experimental pharmacology.

[112]  Atsushi Ogawa,et al.  Rational design of artificial riboswitches based on ligand-dependent modulation of internal ribosome entry in wheat germ extract and their applications as label-free biosensors. , 2011, RNA.

[113]  T. Lithgow,et al.  PUF proteins: repression, activation and mRNA localization. , 2011, Trends in cell biology.

[114]  L. Banaszynski,et al.  A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.

[115]  E. Maxwell,et al.  Signature amino acids enable the archaeal L7Ae box C/D RNP core protein to recognize and bind the K-loop RNA motif. , 2010, RNA.

[116]  T. Hall Expanding the RNA-recognition code of PUF proteins , 2014, Nature Structural &Molecular Biology.

[117]  Zhijian J. Chen,et al.  SnapShot: Pathways of Antiviral Innate Immunity , 2010, Cell.

[118]  Yohei Yokobayashi,et al.  Controlling Mammalian Gene Expression by Allosteric Hepatitis Delta Virus Ribozymes , 2013, ACS synthetic biology.

[119]  D. Walsh,et al.  Tinkering with translation: protein synthesis in virus-infected cells. , 2013, Cold Spring Harbor perspectives in biology.

[120]  M. Elowitz,et al.  Synthetic Biology: Integrated Gene Circuits , 2011, Science.

[121]  H. Sugiyama,et al.  Engineering RNA-protein complexes with different shapes for imaging and therapeutic applications. , 2014, ACS nano.

[122]  Phillip D. Zamore,et al.  Modular Recognition of RNA by a Human Pumilio-Homology Domain , 2002, Cell.

[123]  M. Hentze,et al.  Proteins binding to 5' untranslated region sites: a general mechanism for translational regulation of mRNAs in human and yeast cells , 1994, Molecular and cellular biology.

[124]  Martin Fussenegger,et al.  A synthetic multifunctional mammalian pH sensor and CO2 transgene-control device. , 2014, Molecular cell.

[125]  Y. Benenson RNA-based computation in live cells. , 2009, Current opinion in biotechnology.

[126]  A protein-RNA specificity code enables targeted activation of an endogenous human transcript , 2014, Nature Structural &Molecular Biology.

[127]  A. Hüttenhofer,et al.  Binding of L7Ae protein to the K-turn of archaeal snoRNAs: a shared RNA binding motif for C/D and H/ACA box snoRNAs in Archaea. , 2003, Nucleic acids research.

[128]  Farren J. Isaacs,et al.  RNA synthetic biology , 2006, Nature Biotechnology.

[129]  A. Ogawa Ligand‐Dependent Upregulation of Ribosomal Shunting , 2013, Chembiochem : a European journal of chemical biology.

[130]  G. Leroux-Roels,et al.  Unmet needs in modern vaccinology: adjuvants to improve the immune response. , 2010, Vaccine.

[131]  Florian Groher,et al.  Synthetic riboswitches - A tool comes of age. , 2014, Biochimica et biophysica acta.

[132]  Oberdan Leo,et al.  Key concepts in immunology. , 2010, Vaccine.

[133]  Günter Mayer,et al.  An RNA aptamer that induces transcription. , 2009, Chemistry & biology.

[134]  F. Lienert,et al.  Synthetic biology in mammalian cells: next generation research tools and therapeutics , 2014, Nature Reviews Molecular Cell Biology.

[135]  Travis S. Bayer,et al.  Programmable ligand-controlled riboregulators of eukaryotic gene expression , 2005, Nature Biotechnology.

[136]  D. Dean,et al.  Progress and prospects: nuclear import of nonviral vectors , 2010, Gene Therapy.

[137]  M. Green,et al.  Controlling gene expression in living cells through small molecule-RNA interactions. , 1998, Science.

[138]  C. Mandl,et al.  RNA: the new revolution in nucleic acid vaccines. , 2013, Seminars in immunology.

[139]  R. Albrecht,et al.  MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies , 2013, Nature Biotechnology.

[140]  Martin Fussenegger,et al.  Self-sufficient control of urate homeostasis in mice by a synthetic circuit , 2010, Nature Biotechnology.

[141]  Barbara Fink,et al.  Tetracycline‐aptamer‐mediated translational regulation in yeast , 2003, Molecular microbiology.

[142]  Hirohide Saito,et al.  Three-dimensionally designed protein-responsive RNA devices for cell signaling regulation , 2012, Nucleic acids research.

[143]  Markus Wieland,et al.  Programmable single-cell mammalian biocomputers , 2012, Nature.

[144]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[145]  James A. Stapleton,et al.  Feedback Control of Protein Expression in Mammalian Cells by Tunable Synthetic Translational Inhibition , 2011, ACS synthetic biology.

[146]  Priscilla E. M. Purnick,et al.  The second wave of synthetic biology: from modules to systems , 2009, Nature Reviews Molecular Cell Biology.

[147]  K. Ljungberg,et al.  Self-replicating alphavirus RNA vaccines , 2015, Expert review of vaccines.

[148]  S. Yoshimura,et al.  Synthetic RNA-protein complex shaped like an equilateral triangle. , 2011, Nature nanotechnology.